Jefferson University Hospitals

Physician Profile

Sergio Jimenez, MD

Jefferson University Physician

Academic Title: Professor
Director, Scleroderma Center

Rheumatology (Not Accepting New Patients)

Office Locations

Bluemle Life Sciences Bldg.
233 S. 10th Street, Ste. 509
Philadelphia PA 19107
Phone: (215) 503-5785
Fax: (215) 923-4649

Medical Services

Years in Practice


Board Certifications

  • Internal Medicine

Hospital Affiliation / Admitting Privileges

  • Thomas Jefferson University Hospital

Awards and Honors

Fellow, Royal College of Physicians 2010

Charles Slocumb Award for Excellence in Rheumatology 2009

Master, American College of Rheumatology 2008


Dr. Jimenez's practice is limited to: Scleroderma, Systemic Sclerosis, Nephrogenic Systemic Fibrosis and Fibrosing Disorders


  • San Marcos University, Peru, Medical School


  • Philadelphia General Hospital
  • Hospital of the University of Pennsylvania


  • Mayo Medical Center, Rochester MN
  • Philadelphia General Hospital


  • Hospital of the University of Pennsylvania

Recent Publications

Multiplex assessment of serum cytokine and chemokine levels in idiopathic morphea and vitamin K1-induced morphea

Review article: pathogenesis and clinical manifestations of gastrointestinal involvement in systemic sclerosis

Update of EULAR recommendations for the treatment of systemic sclerosis

Stimulation of transforming growth factor-β1-induced endothelial-to-mesenchymal transition and tissue fibrosis by endothelin-1 (ET-1): A novel profibrotic effect of ET-1

Role of muscarinic-3 receptor antibody in systemic sclerosis: Correlation with disease duration and effects of IVIG

Endothelial to mesenchymal transition (EndoMT) in the pathogenesis of Systemic Sclerosis-associated pulmonary fibrosis and pulmonary arterial hypertension. Myth or reality?

Severe eosinophilic fasciitis: Comparison of treatment with d-penicillamine plus corticosteroids vs. corticosteroids alone

Treatment of rapidly progressive systemic sclerosis: Current and futures perspectives

Biomarkers in systemic sclerosis

Endothelial Cells Expressing Endothelial and Mesenchymal Cell Gene Products in Lung Tissue from Patients with Systemic Sclerosis-Associated Interstitial Lung Disease

Joint and tendon involvement predict disease progression in systemic sclerosis: A EUSTAR prospective study

A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: A EUSTAR prospective study

Analysis of 13 cell types reveals evidence for the expression of numerous novel primate- And tissue-specific microRNAs

The significance of macrophage polarization subtypes for animal models of tissue fibrosis and human fibrotic diseases

Role of cellular senescence and NOX4-mediated oxidative stress in systemic sclerosis pathogenesis

Increased expression of NAPDH oxidase 4 in systemic sclerosis dermal fibroblasts

Induction of a type I interferon signature in normal human monocytes by gadolinium-based contrast agents: Comparison of linear and macrocyclic agents

Role of Cellular Senescence and NOX4-Mediated Oxidative Stress in Systemic Sclerosis Pathogenesis

Altered MCM protein levels and autophagic flux in aged and systemic sclerosis dermal fibroblasts

Collagen content in skin and internal organs of the Tight Skin mouse: An animal model of scleroderma